Skip to main content

Advertisement

Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration

Article metrics

Abstract

Neural tissue repair and regeneration strategies have received a great deal of attention because it directly affects the quality of the patient's life. There are many scientific challenges to regenerate nerve while using conventional autologous nerve grafts and from the newly developed therapeutic strategies for the reconstruction of damaged nerves. Recent advancements in nerve regeneration have involved the application of tissue engineering principles and this has evolved a new perspective to neural therapy. The success of neural tissue engineering is mainly based on the regulation of cell behavior and tissue progression through the development of a synthetic scaffold that is analogous to the natural extracellular matrix and can support three-dimensional cell cultures. As the natural extracellular matrix provides an ideal environment for topographical, electrical and chemical cues to the adhesion and proliferation of neural cells, there exists a need to develop a synthetic scaffold that would be biocompatible, immunologically inert, conducting, biodegradable, and infection-resistant biomaterial to support neurite outgrowth. This review outlines the rationale for effective neural tissue engineering through the use of suitable biomaterials and scaffolding techniques for fabrication of a construct that would allow the neurons to adhere, proliferate and eventually form nerves.

Introduction

The human brain is analogous to a black box of information and unraveling its mysteries is essential to understand its complex relationship with the various components of the peripheral and central nervous systems. This information is vital to probe the causes for various neural disorders and arrive at a plausible therapy for the treatment of ischemic, metabolic, congenital, or degenerative disorders of the central or peripheral nervous systems. Conventionally, autologous grafts are gold standards and have been used to treat neural defects [13]. However, autografts have limitations that include shortage of nerves since it is taken from the patient. Moreover, there is a mismatch of donor-site nerve size with the recipient site, neuroma formation and lack of functional recovery [4, 5]. Allogenic grafts, which are isolated from cadavers, are not limited by supply but suffer from host-graft immune rejection [6]. To overcome immune rejection, several studies have been conducted to examine the potency of acellular nerve grafts [7, 8]. However, as acellular nerve graft lacks viable cells, nerve regeneration and remodeling of extracellular matrix have been delayed [8]. The use of pre-degenerated nerve grafts having high matrix metalloproteinase (MMP) expression shows some potential as it degrades the inhibitory chondroitin sulphate and proteoglycans thereby retaining the ability to promote nerve regeneration even in the absence of cells [8, 9].

Recent advances in nanotechnology [10] and tissue engineering [11, 12] have been found to cover a broad range of applications in regenerative medicine and offer the most effective strategy to repair neural defects. The major determinant in all tissue engineering research is to regulate the cell behavior and tissue progression through the development and design of synthetic extracellular matrix analogues of novel biomaterials to support three-dimensional cell culture and tissue regeneration. Ideal properties of a scaffold for nerve regeneration are biocompatibility, less inflammatory, controlled biodegradability with non-toxic degradative products, porosity for vascularization and cell migration and three-dimensional matrices with appropriate mechanical properties to mimic the extracellular matrix [1315]. Figure 1 shows the various characteristics desired for an ideal scaffold for neural regeneration.

Figure 1
figure1

Ideal properties of scaffold.

Polymeric biomaterials are widely preferred as scaffolds for peripheral and central nerve regeneration both in vitro and in vivo [1619]. There is a wide choice of polymers available with programmable biodegradability, non-toxic/non-inflammatory nature, mechanical properties similar to the tissue to be replaced, high porosity that promotes cell attachment and growth, economical and simple manufacturing processes along with a potential for chemical modification leading to increased interaction with normal tissue [20]. Several techniques such as nanofiber self-assembly, solvent casting and particulate leaching, gas foaming, emulsification/freeze-drying, liquid-liquid phase separation, electrospinning and computer aided design and manufacturing techniques have been employed to fabricate tissue engineering scaffolds with varying degrees of success [2124]. Various attempts made towards repairing neural defects have been discussed in the following sections along with the rationale behind selection of a suitable scaffold material for successful neural tissue engineering.

Response to Injury & Repair

Regeneration strategies for peripheral and central nervous system damage have not been very successful due to lack of knowledge about the mechanisms of nerve injury and repair [25]. Nerve cells have been found capable of easily bridging gaps of less than 6 mm [26]. Thus, regenerating nerves across larger gaps are medically challenging phenomenon since, injuries of less impact in peripheral nervous system (PNS) heal by formation of fibrin cable across the gap [4]. This eventually allows the Schwann cells to migrate from both the nerve ends, thereby orienting the bungner bands to promote neurite outgrowth [27]. Presently, researchers have investigated a suitable strategy to enhance the formation of Bungner bands and have identified microstructured biomaterial filaments provide a better topography, promoting bungner band formation even in the absence of biological factors [28]. Additionally, after injury, the protein synthesis and degradation machinery in axons play a major role in the initiation of growth cone formation [29]. However, the myelination of central nervous system (CNS) is distinct from that of peripheral nervous system (PNS). Astrocytes and oligodendrocytes are found in the CNS which also marks a key difference between CNS and PNS in their response to injury [16]. In the case of CNS, spontaneous regeneration is impossible due to its own inhibitory environment [16, 25]. This includes glial scar formation and accumulation of myelin-associated inhibitors such as chondroitin sulphate proteoglycans [30, 31]. Moreover, the primary injury in CNS expands further by damaging the nerve cells due to secretion of free radicals from the blood via the blood-brain barrier resulting in secondary injury which impedes the regeneration potency of these cells [32]. Many strategies have been attempted to improve the regenerative potency of neurons such as cell therapy, exogenous delivery of growth factors and tissue engineering approaches; each in turn restores the function with varying degrees of success.

Regeneration Potential of Neural Cells

Guenard et al. have observed that the potential use of autologous Schwann cells that aid in CNS regeneration [33]. This novel approach modifies the environment of the CNS by transplanting Schwann cells which enhances axonal regeneration. This may be due to the fact that Schwann cells are the myelinating glial cells in the PNS and are known to play a key role in Wallerian degeneration and subsequent CNS regeneration [4, 20, 34, 35]. Schwann cells promote neural regeneration and remyelination by secreting adhesion molecules L1 and neural cell adhesion molecule (N-CAM), extracellular molecules (collagen and laminin) and a number of tropic factors such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) [36]. Though the Schwann cells have regenerative potential, studies have shown the undesirable effects such as inhibition of Schwann cell migration into the CNS, delayed functional recovery and in certain cases, the Schwann cells may follow its original white matter pathway instead of the intended grey matter pathway [36].

The nearly impossible task of rebuilding the nervous system has since undergone a dramatic transformation with the discovery of stem cells [30, 37]. The differentiation of neural stem cells to specific cell lineages has been controlled by constructing scaffolds of composite biomaterials that consist of extracellular matrix (ECM) components and growth factors [38]. The embryonic stem cell-derived oligodendrocytes have been recognized to myelinate axons in culture and to replace lost myelin in the injured adult CNS [39]. Human embryonic stem cell-derived oligodendrocyte progenitors when transplanted into injured spinal cords of rat proved to be a safe procedure, resulting in improved locomotor function [40]. The ideal cell culture conditions for embryonic stem cell proliferation and differentiation in fibrin-based scaffolds has been identified for neural tissue engineering applications [41].

Investigations on astrocytes have supported its role in the induction of neurogenesis from adult neural stem cells [42]. The directed growth of astrocytes on polymer substrates provides an innovative approach to promote controlled outgrowth and differentiation of neural stem cells [43]. Though the astrocytes contribute the cytotrophic effects in neural repair, at certain stages in response to injury it inhibits neurite outgrowth by releasing signals inhibiting neurite extension [44]. Researchers have tried to improve the cytotropic effects of astrocytes in regeneration by harnessing its cytotoxic effects [44].

In addition to these cells, olfactory ensheathing cells (OEC) [45] and trans-differentiated mesenchymal stem cells [46] have also been identified to promote axonal regeneration and functional recovery at the site of a spinal cord injury. The olfactory system promotes the axonal outgrowth into the CNS from the PNS due to the presence of both peripheral and central tissues [47]. Thus the phenotype of OEC is closer to the Schwann cells and has the properties of both Schwann cells and Astrocytes [36]. The transplantation of OEC enhances its migration [48] and secretion of extracellular molecules type IV collagen, tropic factors such as vascular endothelial growth factor (VEGF), NGF and BDNF [36]. The OEC are found to reduce the secondary neuron apoptosis and the degree of functional recovery after implantation of OEC is rapid as compared to Schwann cells [36, 49].

Although the stem cell therapy seems to be promising, it is very hard to control the cell proliferation and differentiation into three-dimensional architectures of tissues [50]. Moreover, the use of stem cells to repair spinal cord has been reported to cause adverse side effects such as allodynia in unaffected forepaws of the rats [51]. Hence, it is a challenge to provide optimized conditions for controlled and adequate differentiation of transplanted stem cells in order to develop a safe stem cell-based therapy. Certain factors in stem cell-based therapy such as carcinogenicity and ethical concerns in the use of embryonic stem cells remain unanswered thereby limiting their use.

Delivery of growth factors to promote regeneration

Growth factor signaling play a major role in tissue repair process. In addition to maximizing the intrinsic regenerative potency of endogenous progenitor cells, bioactive factors are also used to manipulate the differentiation and growth of exogenous stem cells [52]. The discovery of Nerve Growth Factor (NGF) has been more helpful to support ailing neurons by promoting nerve regeneration [53, 54]. However, targeting and retaining the required concentration of these factors at the site of injury is quite complicated phenomenon. The nerve guidance channels provide a conduit for the diffusion of these growth factors and reduce the glial scar formation [16]. The sustained release of lipoplexes (complexes of liposomes and oligonucleotides) has shown promise to repair nerve injury by expressing neurotrophic factor [55, 56]. Moreover, restoring the activity of such proteins is pretty challenging. Although Poly (D,L-lactic-co-glycolic acid) (PLGA) microspheres has been demonstrated as a potential carrier of growth factors, the main concern is the inactivation of proteins due to the release of acidic products. This problem can be overcome by using polyphosphoesters as a delivery vehicle [57]. Recently, Sun et al. targeted a collagen binding domain-nerve growth factor β (CBD-NGF β) to nerve extracellular matrix collagen to restore the peripheral nerve function in rat sciatic nerves [58]. They have confirmed the functional recovery by performing walking track, histological and electrophysiological analysis. These discoveries of regenerative capacity in adult central nervous system hold promise to neural victims for complete recovery [58]. Currently electrospun nanofibrous scaffold become a successful and safe delivery vehicle since it can simultaneously act as a scaffold and improve contact guidance while delivering the bioactive factors in controlled and sustained way [59].

Biomaterials in Nerve Regeneration

Natural polymers (chitosan, chitin, collagen, gelatin, alginate), synthetic non-degradable polymers (silicone), synthetic biodegradable polymers such as PLGA, poly (ε-caprolactone (PCL), poly L-lactic acid (PLLA) and conducting polymers (polypyrrole, polyaniline) have been used in various nerve regeneration approaches. An ideal nerve conduit should be thin, flexible, porous, biocompatible, biodegradable, compliant, neuroinductive, neuroconductive and with appropriate surface and mechanical properties [14]. Although these biomaterials promise to fulfill some of the above stated criteria, they have some demerits which have to be overcome to meet the specific tissue engineering applications. For example, a scaffold made from non-degradable materials should be avoided to prevent the chronic inflammation and compression of nerve over time and therefore it is preferable to use biodegradable materials [26]. Even in biodegradable materials, surface erosion is desired over bulk erosion, since it permits the scaffolds to retain their structural stability for a longer time after implantation. Therefore, a surface eroding polymeric scaffold is expected to provide better contact guidance cues continuously for nerve regeneration. This fact is reinforced by a recent report on the use of poly (glycerol sebacate) (PGS) as a nerve guide material due to its surface erodible and elastomeric properties [60]. In general, researchers have attempted to improve the neural scaffold properties by several novel fabricating techniques such as polymer blending and electrospinning, incorporating nerve growth factors in the scaffold [61], and improving the wettability of the scaffold surface by surface modifications. Table 1[6278] summarizes a list of biomaterials and techniques that have been used to promote nerve regeneration.

Table 1 Modified biomaterials attempted to promote nerve regeneration.

One of the most important properties needed for successful graft uptake by host tissues is mechanical stability and compatibility of the scaffolds. For nerve tissue engineering, the scaffold should be pliable, harmless to the surrounding tissues, resist structural collapse during implantation [79] which may lead to necrosis and inflammation. Many approaches have been attempted to improve the properties of common biomaterials to make them suitable for neural tissue engineering. A highly flexible PLGA scaffold was developed by microbraiding method to improve its flexibility and porosity [75]. Suitability of PLLA porous conduits fabricated by extrusion technique has been evaluated in vivo for scaffold applications [8082]. Biomechanical properties of electrospun PCL scaffolds were improved by thermal treatment while retaining the structural stability, gross appearance, porosity and fiber diameter [66].

Polymer blending offers one of the most successful methods to develop a suitable scaffold with all preferred properties for specific tissue engineering applications [83, 84]. For example, a polymer blend of the brittle-natured PLGA and a soft, elastic polymer such as polyurethane or poly (ethyleneglycol) (PEG) have been found to exhibit much greater elasticity than PLGA itself [85]. Chitosan-gelatin composite films show improved mechanical property and nerve cell affinity due to its softness and elastic properties [84]. Fabrication of biodegradable nerve guidance channels based on chitin/chitosan has been carried out for improvements in nerve tissue engineering [86]. An artificial nerve graft of chitosan/polyglycolic acid (PGA) blend has been used to bridge a 30 mm sciatic nerve defect in a large animal model [87]. Repairing long-term delayed peripheral nerve defects is clinically very challenging which includes number of various factors such as availability of surviving Schwann cells, worsening of growth permissive environment by disintegration of Schwann cell basement membrane [88]. Jiao et al. attempted to bridge the long term delayed defects of rat sciatic nerves using biodegradable chitosan-PGA graft and measured the functional recovery using histological and electrophysiological assays [88]. They have observed very few functional (regenerated) nerve fibers and poor growth support in delayed repair groups can improve the potency of chitosan/PGA grafts in delayed repair [88].

Cell adhesion property of a scaffold mainly depends on its surface characteristics such as charge density and wettability [66, 89]. Most of the synthetic biodegradable materials are hydrophobic (PLGA, PCL, PHB etc.,) which limits their use as tissue engineering scaffolds. Thus surface modification either by coating of the surface with ECM proteins such as laminin, fibronectin, collagen or by incorporating specific adhesion peptide sequences like RGD and IKVAV, YIGSR can induce hydrophilicity which in turn improves the cell adhesion property of the scaffold. Currently the cell adhesion property of the materials such as methyl cellulose [90], alginate [91], poly (hydroxyethyl methacrylate) (PHEMA) [92], poly (hydroxybutyrate) (PHB) [65] has been improved by modifying their surface with specific peptide sequences.

Different approaches have been used to improve the biocompatibility. The performance of neural implants has been improved by using the layer-by-layer (LbL) technique [93]. A photochemical method has been employed to make PHEMA bound neural growth factor (NGF) more bioactive [94].

Polymeric Scaffolds as Extracellular Matrix Analogues

Scaffolding is a temporary framework used to support cells in the construction or repair of tissue. Surface chemistry of scaffold materials is considered to be the most important parameter in tissue engineering [95]. The extracellular matrix (ECM) in biological systems holds the cells together and provides a medium for the cells to interact and migrate [96]. Thus it is desirable that the synthetic scaffold mimics the ECM in promoting cell adhesion, proliferation, and differentiation in vitro and in vivo [66, 97]. Two dimensional tissue cultures as the name suggests offer only a monolayer of cells as opposed to the three-dimensional nature of tissue in organisms [98]. Hence it is an inadequate model for complex cellular interactions and is prone to hydrodynamic damage in bioreactors [98]. Three-dimensional tissue cultures have received much consideration than two dimensional cultures because of their superior hydrodynamic protection, higher surface area per unit volume, better cell-cell interaction and improved regeneration of the injured tissue [99]. Improved functional recovery and formation of neural networks to bridge the gap following spinal cord injury has been reported in the transplantation of stem cells on polymeric scaffolds than the transplantation of stem cell alone [30, 100].

Geometric Cues - Structure of Scaffolds

Well defined nanostructured topographical cues such as grooves, ridges, pores, nodes can influence cell-substrate interaction by promoting cell adhesion, migration, proliferation and differentiation to new tissue [101]. For example nanopatterned gratings on poly(methyl methacrylate) (PMMA) and poly(dimethylsiloxane) (PDMS) were used to induce alignment and elongation of smooth muscle cells [101]. There are different scaffold fabrication techniques such as solvent casting, particulate leaching, melt molding etc., to fabricate scaffolds of various geometries with the desired porosity and surface area for cell scaffolding [102]. Among the different forms of scaffold (nanofibers, sintered matrix, nanofoams, hydrogels, nanotubes, etc.,) hydrogels and nanofibers have been extensively investigated for use as a scaffold in neural regeneration.

In recent years, hydrogels have received considerable attention as a suitable scaffold material in neural tissue engineering [103, 104]. Hydrogels provide appropriate chemical, mechanical and spatial microenvironment akin to the natural ECM to support the neurite extension for cell proliferation, differentiation and axon extension [95, 105]. Moreover they are biocompatible and possess similar mechanical properties to soft tissue, low interfacial tension, and are good injectable scaffolds. A biocompatible polymeric hydrogel has been shown to induce reconstruction of the rat spinal cord after chronic compression-produced injury [55, 106]. Neuroinductive and neuroconductive properties of a biocompatible heterogeneous poly [N-(2-hydroxypropyl) methacrylamide] (PHPMA) hydrogel have been used extensively to repair tissue defects in the central nervous system by promoting the formation of a tissue matrix and axonal growth [107]. Poly (2-hydroxyethyl methacrylate) (PHEMA) hydrogels have also proved to be useful in neural tissue engineering applications [77]. Cells get introduced easily into the liquid precursors of the gel due to its smaller mesh size. Production of cell-based hydrogel polymer constructs has been envisioned for tissue replacement in the central nervous system with combined physico-chemical properties such as biocompatibility, stability, porosity and hydrophilicity along with biological recognition such as expression of biospecific surface receptors and synthesis of bioactive molecules [108]. It has been reported that the use of polyethylene glycol (PEG) hydrogel as a cell carrier supported the neural precursor cell survival, expansion and differentiation in culture [109]. The evaluation of growth properties of Schwann cells on chitosan proved its biocompatibility [110]. Implantation of three-dimensional polymeric hydrogel into the site of injury has been attempted to enhance the axonal recovery [111]. Three-dimensional polylysine-functionalized polysaccharide hydrogel system promises to be a good scaffolding material for neural tissue engineering [70, 112]. Three-dimensional peptide channels within hyaluronan (HA) hydrogel matrix modified with S-2-nitribenzyl cysteine (HA-SNBC) is expected to serve as a temporary scaffold for guided axonal regeneration in vivo [113]. Among the various polymeric hydrogel tubes that have been designed and studied for their suitability as neural scaffolds, reinforced coil tube expressed excellent mechanical properties equivalent to soft tissues and they supported neural outgrowth. Also it was observed that the conducting velocity of the construct exactly matched that of native axons [114].

Nanofiber Properties & Electrospinning Technology

Nanofiber seems to be most promising substrate in tissue engineering applications due to its resemblance to native extracellular matrix [67, 115, 116]. Nanofiber is a broad phrase generally referring to fibrous structures with a diameter less than 1 micron. Figure 2 shows the scanning electron micrograph of electrospun PLGA-Polyaniline nanofibers with smooth defect-free morphology for neural tissue engineering. Extraordinary mechanical strength and high surface area to volume ratio makes the nanofiber more suitable for neural tissue engineering [10, 117]. Porous polymeric nanofibrous scaffold using biodegradable poly (L-lactic acid) (PLLA) fabricated by liquid-liquid phase separation method resembles ECM of natural collagen to support neuron differentiation and neurite outgrowth [22]. However, it is very difficult to maintain the fiber diameter and alignment using this technique. Likewise, various techniques have been reported to develop nanofibers namely, template synthesis, phase separation, self-assembly, drawing and electrospinning [115]. Among these techniques, electrospinning offers more advantages due to its ease of fabrication. Nanofibrous conduit comprising poly (D,L-lactide-co-glycolide) and poly(ε-caprolactone) (PCL/PLGA) were found to promote nerve regeneration across 10 mm nerve gap in rat sciatic nerve [118]. PLGA random nano and microfibers, aligned microfibers and films were investigated for C17.2 neural stem cell culture and recognized the differentiation of neurons along the fiber direction [119].

Figure 2
figure2

Electrospun PLGA-PANi nanofibers.

PLLA nanofibrous scaffolds were developed via electrospinning and found to support neural stem cell (NSC) adhesion, outgrowth and differentiation [21]. Suitability of aligned electrospun PLLA nanofibers compared with random nanofibers was evaluated for neural tissue engineering in terms of their fiber alignment and dimension [21]. The aligned nanofibers were found to support the orientation of cells and improve the neurite outgrowth and contact guidance [21, 67]. Based on the experimental results, this study recommended the aligned PLLA nanofibrous scaffold as a potential cell carrier in neural tissue engineering [21, 119]. The parameters such as viscosity, conductivity, surface tension of polymer solution, applied electric potential, flow rate, and distance between the electrodes are to be optimized while carrying on the electrospinning process [120]. It is also observed that the orientation of fiber became disordered at the top layer of the electrospun mesh when the collecting time was longer than thirty minutes due to the residual charges on the collecting fibers [21]. The desirable properties of electrospun nanofiber scaffolds seem to offer a promising alternative towards the treatment of neural defects. Aligned electrospun collagen/PCL fibers supports cell proliferation, glial migration, orientation of neurite outgrowth, suggested its suitability as nerve implants [71]. Aligned electrospun PCL fibers have been found to up regulate specific genes such as P0 and down regulate NCAM - 1 on cultured Schwann cells thereby promoting the Schwann cell maturation [67]. Significantly higher Schwann cell migration and neurite outgrowth was observed on uniaxially aligned fibers of poly (acrylonitrile-co-methylacrylate) (PAN-MA) developed by electrospinning than on random fibers [121].

Other Approaches

Fabrication of a multi-channel scaffold using injection molding with solvent evaporation technique has been demonstrated to promote spinal cord axon regeneration [122]. A new facile method named 'fiber stimulating technique' used to fabricate oriented PHEMA scaffolds successfully for neural tissue engineering, promises to be more effective and reproducible [77]. Melt compression and melt extrusion are also considered to be viable techniques to prepare nerve guides [14]. Innovative fabrication techniques such as wire mesh method and mandrel adhesion method are used to prepare multi-channel biodegradable nerve guides without the requirement of complex instrumentation, acidic conditions or exposure to extreme temperatures [123]. Designing of biodegradable PLGA hollow fiber by wet phase inversion technique has been attempted for the development of nerve tract guidance conduit [13]. Micropatterning is a novel patterning technique for biodegradable polymers and is reported to enhance peripheral nerve regeneration by controlling the alignment of Schwann cells [124126]. Fabrication techniques continue to evolve novel routes to provide the most suitable nanostructure topography for adequate neural growth.

Electrical Cues

Human body responds to electrical fields and the key component of neural communication in the body is the action potential generated at the synapse. This implies that an ideal neural scaffold should also possess electrical conductivity to promote neurite outgrowth and thereby enhance nerve regeneration in culture. The use of electrically conducting polymers in biomedical applications has become more attractive due to its tailor-made specificities [127]. Polypyrrole (Ppy), a well-known conducting polymer used in biomedical applications has been found to enhance the nerve regeneration by electrical stimulation [128, 129]. Moreover, the antioxidant property of polypyrrole and polyaniline makes them more attractive substrates for tissue engineering applications [130, 131] as they could scavenge any free radicals at the site of injury minimizing scar formation which is a bane of neural regeneration. The structures of polythiophene, polyaniline and polypyrrole are shown in figure 3.

Figure 3
figure3

Chemical structure of conducting polymers.

A comparative study was made on the efficacy of two different laminin fragments p20 and p31 as dopants in conducting polypyrrole surfaces for in vitro growth of neurons. The results indicated that p20 as dopant supported the highest neuronal density than p31 dopant [132]. Conducting Ppy/PDLLA/PCL composites have been implanted to bridge the gap of 8 mm in rat sciatic nerves and shown to promote the nerve cell proliferation and axon regeneration using electrical cues [69]. The rats were gradually recovered the mobility in operated limb over the period of 2 months [69]. Moreover, the immunohistological analysis and transmission electron microscopy of harvested implants demonstrated the presence of newly formed myelinated axons and Schwann cells similar to that of native nerve [69]. Recently the cell adhesion property of polypyrrole has been improved by chemical conjugation of a functionalized carboxylic acid group with RGD peptide [133]. The suitability of poly ethylene dioxythiophene (PEDOT) as a biomaterial was evaluated by studying the adhesion and proliferation of epithelial cells and was demonstrated that the electroactive substrate favors cell adhesion [134]. Though the mechanism in which electrical stimulation promotes nerve regeneration is not clearly understood, several possible hypothesis have been postulated to elucidate their role in nerve regeneration. Some of the plausible reasons include electrophoretic redistribution of cell surface receptors, activate growth controlling transport process and altered adsorption of adhesive proteins [135]. The later hypothesis has been proved by stimulating the adsorption of fibronectin (ECM adhesive glycoprotein) from serum to polypyrrole surface via electrical stimulation, which subsequently facilitate the neuronal attachment and neurite outgrowth [128].

However, these conducting polymers are non-biodegradable and questions on their safety in biological systems have delayed their wide-spread use in neural conduits.

Future Prospective

Many Challenges still remain unwrapped. Though the researchers have found different strategies to achieve the functional recovery to some extent, regaining the maximal or full function remains unexplored. There are some issues listed below have to be addressed in future; (1) the first inescapable conclusion arising over various reports on nerve tissue engineering by super positioning of all these approaches is crucial for promoting the neural regeneration on multiple levels (2) the probable hazards of long term usage of such novel biomaterials on human health yet to be revealed (3) the need for novel Biomaterials and approaches has to be established in order to treat the delayed nerve injuries in patients who have neurological disorders.

Conclusion

An ideal nerve conduit requires a suitable porous, biocompatible, biodegradable, neuroconductive, neuroinductive, infection resistant, compliant three-dimensional biomaterial scaffolds. The engineered construct should also mimic the ECM architecture and porosity, desirable for cell attachment and other vital functions. Biomedical nanotechnology, electrospinning techniques and tissue engineering methods give us exciting insights to the design of a scaffold with good electrical, mechanical, biological properties and compliance match closely resembling the native ECM. Such scaffolds can also avoid infections, multiple surgeries and additional cost to the patient. An array of methods has been used for polymer scaffold preparation but electrospinning scores high due to its ease of operation, better control of fiber properties and desirable results. Lot of synthetic biodegradable polymers has been used till date but at the same time suffer from the demerits of release of acidic degradation products, hydrophobicity, poor processability and loss of mechanical properties. Also they support elongation and partial collapse of nerves. Hydrogels mimic soft tissue properties but are very difficult to sterilize and handle due to their fragile nature. A new strategy using polymers like polypyrrole, polyaniline etc., having conducting properties are being investigated for neural tissue engineering to stimulate neurite extension. However, the biocompatibility of these polymers has not been conclusively proved till now. It is seen that though different classes of biomaterials are available, no single material is enough to improve the scaffold properties for nerve regeneration. Hence, the major challenge in developing a scaffold lies primarily in the choice of a blend of biomaterials with the correct combination of properties. The field is still wide open to design the most appropriate polymer scaffold with all the vital conditions and properties for effective neural applications in vivo.

References

  1. 1.

    Amilo S, Yanez R, Barrios RH: Nerve regeneration in different types of grafts: experimental study in rabbits. Microsurgery. 1995, 16: 621-630. 10.1002/micr.1920160908.

  2. 2.

    Bertelli JA, Orsal D, Mira JC: Median nerve neurotization by peripheral nerve grafts directly implanted into the spinal cord: anatomical, behavioural and electrophysiological evidences of sensorimotor recovery. Brain Res. 1994, 644: 150-159. 10.1016/0006-8993(94)90358-1.

  3. 3.

    Nikkhah G, Carvalho GA, Samii M: Nerve transplantation and neurolysis of the brachial plexus after post-traumatic lesions. Orthopade. 1997, 26: 612-620.

  4. 4.

    Ravi VB: Peripheral nerve regeneration: An opinion on channels, scaffolds and anisotropy. Biomaterials. 2006, 27: 3515-3518.

  5. 5.

    Yu X, Bellamkonda RV: Tissue-engineered scaffolds are effective alternatives to autografts for bridging peripheral nerve gaps. Tissue Eng. 2003, 9: 421-430. 10.1089/107632703322066606.

  6. 6.

    Trumble TE: Peripheral nerve transplantation: the effects of predegenerated grafts and immunosuppression. J Neural Transplant Plast. 1992, 3: 39-49. 10.1155/NP.1992.39.

  7. 7.

    Kim B-S, Yoo JJ, Atala A: Peripheral nerve regeneration using acellular nerve grafts. J Biomed Mater Res. 2004, 68A: 201-209. 10.1002/jbm.a.10045.

  8. 8.

    Krekoski CA, Neubauer D, Graham JB, Muir D: Metalloproteinase-dependent predegeneration in vitro e nhances axonal regeneration within acellular peripheral nerve grafts. J Neurosci. 2002, 22: 10408-10415.

  9. 9.

    Hasan NA, Neumann MM, Souky MA, So KF, Bedi KS: The influence of predegenerated nerve grafts on axonal regeneration from prelesioned peripheral nerves. J Anat. 1996, 189: 293-302.

  10. 10.

    Jain KK: Role of nanotechnology in developing new therapies for disease of the nervous system. Nanomed. 2006, 1: 9-12. 10.2217/17435889.1.1.9.

  11. 11.

    Sarah ES, Andrés JG, Michelle CL: Thermoreversible laminin-functionalized hydrogel for neural tissue engineering. J Biomed Mater Res. 2006, 77A: 718-725. 10.1002/jbm.a.30638.

  12. 12.

    Zhang L, Webster TJ: Review-Nanotechnology and nanomaterials: Promises for improved tissue regeneration. Nano Today. 2009, 4: 66-80. 10.1016/j.nantod.2008.10.014.

  13. 13.

    Wen X, Tresco PA: Fabrication and characterization of permeable degradable poly(DL-lactide-co-glycolide) (PLGA) hollow fiber phase inversion membranes for use as nerve tract guidance channels. Biomaterials. 2006, 27: 3800-3809. 10.1016/j.biomaterials.2006.02.036.

  14. 14.

    Verreck G, Chun I, Li Y, Kataria R, Zhang Q, Rosenblatt J, Decorte A, Heymans K, Adriaensen J, Bruining M, Van Remoortere M, Borghys H, Meert T, Peeters J, Brewster ME: Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole. Biomaterials. 2005, 26: 1307-1315. 10.1016/j.biomaterials.2004.04.040.

  15. 15.

    Amado S, Simoes MJ, Armada da Silva PAS, Luýs AL, Shirosaki Y, Lopes MA, Santos JD, Fregnan F, Gambarotta G, Raimondo S, Fornaro M, Veloso AP, Varejao ASP, Maurýcio AC, Geuna S: Use of hybrid chitosan membranes and N1E-115 cells for promoting nerve regeneration in an axonotmesis rat model. Biomaterials. 2008, 29: 4409-4419. 10.1016/j.biomaterials.2008.07.043.

  16. 16.

    Schmidt CE, Leach JB: Neural tissue engineering: strategies for repair and regeneration. Annu Rev Biomed Eng. 2003, 5: 293-347. 10.1146/annurev.bioeng.5.011303.120731.

  17. 17.

    Geller HM, Fawcett JW: Building a bridge: engineering spinal cord repair. Exp Neurol. 2002, 174: 125-136. 10.1006/exnr.2002.7865.

  18. 18.

    Bellamkonda R, Ranieri JP, Bouche N, Aebischer P: Hydrogel-based three-dimensional matrix for neural cells. J Biomed Mater Res. 1995, 29: 663-671. 10.1002/jbm.820290514.

  19. 19.

    Carbonetto ST, Gruver MM: Nerve fiber growth on defined hydrogel substrates. Science. 1982, 216: 897-899. 10.1126/science.7079743.

  20. 20.

    Freed LE, Vunjak-Novakovic G, Biron RJ, Eagles DB, Lesnoy DC, Barlow SK, Langer R: Biodegradable polymer scaffolds for tissue engineering. Nat Biotechnol. 1994, 12: 689-693. 10.1038/nbt0794-689.

  21. 21.

    Yang F, Murugan R, Wang S, Ramakrishna S: Electrospinning of nano/micro scale poly (L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials. 2005, 26: 2603-2610. 10.1016/j.biomaterials.2004.06.051.

  22. 22.

    Yang F, Murugan R, Ramakrishna S, Wang X, Ma YX, Wang S: Fabrication of nano-structured porous PLLA scaffold intended for nerve tissue engineering. Biomaterials. 2004, 25: 1891-1900. 10.1016/j.biomaterials.2003.08.062.

  23. 23.

    Yang Y, Laporte LD, Rives CB, Jang J, Lin W, Shull KR, Shea LD: Neurotrophin releasing single and multiple lumen nerve conduits. J Control Release. 2005, 104: 433-446.

  24. 24.

    Aijun W, Qiang A, Wenling C, Mingzhi Y, Qing H, Lijun K, Ling Z, Yandao G, Xiufang Z: Porous chitosan tubular scaffolds with knitted outer wall and controllable inner structure for nerve tissue engineering. J Biomed Mater Res. 2006, 79A: 36-46. 10.1002/jbm.a.30683.

  25. 25.

    An Y, Tsang KKS, Zhang H: Potential of stem cell based therapy and tissue engineering in the regeneration of the central nervous system. Biomed Mater. 2006, 1: R38-R44. 10.1088/1748-6041/1/2/R02.

  26. 26.

    Haile Y, Haastert K, Cesnulevicius K, Stummeyer K, Timmer M, Berski S, Drager G, Gerardy-Schahn R, Grothe C: Culturing of glial and neuronal cells on polysialic acid. Biomaterials. 2007, 28: 1163-1173. 10.1016/j.biomaterials.2006.10.030.

  27. 27.

    Young-tae K, Valerie KH, Satish K, Ravi VB: The role of aligned polymer fiber-based constructs in the bridging of long peripheral nerve gaps. Biomaterials. 2008, 29: 3117-3127. 10.1016/j.biomaterials.2008.03.042.

  28. 28.

    Victor TR, Brigitte K, Susanne N, Sven O, Burkhard S: Strategies for inducing the formation of bands of Büngner in peripheral nerve regeneration. Biomaterials. 2009, 30: 5251-5259. 10.1016/j.biomaterials.2009.07.007.

  29. 29.

    Laura FG, Chin LT, James WF: The role of local protein synthesis and degradation in axon regeneration. Fawcett. Experimental Neurology. 2009,

  30. 30.

    Yi X, Yuan-Shan Z, Chen-Guang Z, Bao-ling D, Liu-Min H, Da-Ping Q, Wei Z, Jun-Mei W, Jin-Lang W, Yan L, Jun L: Synaptic transmission of neural stem cells seeded in 3-dimensional PLGA scaffolds. Biomaterials. 2009, 30: 3711-3722. 10.1016/j.biomaterials.2009.03.046.

  31. 31.

    Richmond AT, Justin A, John B, Corey M, Stanley H, Anthony C: Neural tissue co-culture with mesenchyme to investigate patterning of peripheral nerve during murine embryonic limb development. Cytotechnology. 2004, 46: 173-182. 10.1007/s10616-005-3099-2.

  32. 32.

    Spilker MH, Yannas IV, Hsu HP, Norregaard TV, Kostyk SK, Spector M: The effects of collagen-based implants on early healing of the adult rat spinal cord. Tissue Eng. 1997, 3: 309-317. 10.1089/ten.1997.3.309.

  33. 33.

    Xu XM, Guenard V, Kleitman N, Bunge MB: Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol. 1995, 351: 145-160. 10.1002/cne.903510113.

  34. 34.

    Girard C, Bemelmans A, Dufour N, Mallet J, Bachelin C, Nait-Oumesmar B, Evercooren AB, Lachapelle F: Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci. 2005, 25: 7924-7933. 10.1523/JNEUROSCI.4890-04.2005.

  35. 35.

    Thompson DM, Buettner HM: Neurite outgrowth is directed by schwann cell alignment in the absence of other guidance cues. Ann Biomed Eng. 2006, 34: 161-168. 10.1007/s10439-005-9013-4.

  36. 36.

    Samadikuchaksaraei A: Review--An overview of tissue engineering approaches for management of spinal cord injuries. J NeuroEngineering Rehabil. 2007, 4: 15-10.1186/1743-0003-4-15.

  37. 37.

    Barker RA, Jain M, Armstrong RJE, Caldwell MA: Stem cells and neurological disease. J Neurol Neurosurg Psychiatry. 2003, 74: 553-557. 10.1136/jnnp.74.5.553.

  38. 38.

    Nakajima M, Ishimuro T, Kato K, Ko IK, Hirata I, Arima Y, Iwata H: Combinatorial protein display for the cell-based screening of biomaterials that direct neural stem cell differentiation. Biomaterials. 2007, 28: 1048-1060. 10.1016/j.biomaterials.2006.10.004.

  39. 39.

    Liu S, Qu Y, Stewart TJ, Howard MJ, Chakrabortty S, Holekamp TF, McDonald JW: Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. PNAS. 2000, 97: 6126-6131. 10.1073/pnas.97.11.6126.

  40. 40.

    Frank C, Monica MS, Gabriel N, Hans SK: Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regenerative Med. 2006, 1: 469-479. 10.2217/17460751.1.4.469.

  41. 41.

    Willerth SM, Arendas KJ, Gottlieb DI, Sakiyama-Elbert SE: Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials. 2006, 27: 5990-6003. 10.1016/j.biomaterials.2006.07.036.

  42. 42.

    Song H, Stevens CF, Gage FH: Astroglia induce neurogenesis from adult neural stem cells. Nature. 2002, 417: 39-44. 10.1038/417039a.

  43. 43.

    Recknor JB, Recknor JC, Sakaguchi DS, Mallapragada SK: Oriented astroglial cell growth on micropatterned polystyrene substrates. Biomaterials. 2004, 25: 2753-2767. 10.1016/j.biomaterials.2003.11.045.

  44. 44.

    David RN, Andrew ER, Malcolm KH, John SF, David IF: Neurite infiltration and cellular response to electrospun polycaprolactone scaffolds implanted into the brain. Biomaterials. 2009, 30: 4573-4580. 10.1016/j.biomaterials.2009.05.011.

  45. 45.

    Johansson S, Lee IH, Olson L, Spenger C: Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions. Brain. 2005, 128: 2961-2976. 10.1093/brain/awh644.

  46. 46.

    Keilhoff G, Stang F, Goihl A, Wolf G, Fansa H: Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination. Cell Mol Neurobiol. 2006, 26: 1233-1250. 10.1007/s10571-006-9029-9.

  47. 47.

    Barnett SC: Olfactory enshealthing cells: Unique glial cell types?. Journal of Neurotrauma. 2004, 21: 375-382. 10.1089/089771504323004520.

  48. 48.

    Huang Z, Wang Y, Cao L, Su Z, Zhu Y, Chen Y, Yuan X, He C: Migratory properties of cultured olfactory ensheathing cells by single-cell migration assay. Cell Research. 2008, 18: 479-490. 10.1038/cr.2008.38.

  49. 49.

    Xiao-dong YU, Zhup-jing LUO, Lin Z, Kai G: Effects of olfactory ensheathing cells on hydrongen peroxide-induced apoptosis in cultured dorsal root ganglion neurons. Chin Med J. 2007, 120: 1438-1443.

  50. 50.

    Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R: Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. PNAS. 2003, 100: 12741-12746. 10.1073/pnas.1735463100.

  51. 51.

    Hofstetter CP, Holmstrom NAV, Lilja JA, Schweinhardt P, Hao J, Spenger C, Wiesenfeld-Hallin Z, Kurpad SN, Frisen J, Olson L: Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nature Neuroscience. 2005, 8: 346-353. 10.1038/nn1405.

  52. 52.

    Kimberley DN, Michael WM: Poly(d,l lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells. Biomaterials. 2004, 25: 5763-5771. 10.1016/j.biomaterials.2004.01.027.

  53. 53.

    Sofroniew MV, Howe CL, Mobley WC: Nerve Growth Factor signaling, Neuroprotection, and Neural repair. Annu Rev of Neurosci. 2001, 24: 1217-1281. 10.1146/annurev.neuro.24.1.1217.

  54. 54.

    Babensee JE, McIntire LV, Mikos AG: Growth Factor Delivery for Tissue engineering. Pharm Res. 2000, 17: 497-504. 10.1023/A:1007502828372.

  55. 55.

    Whittlesey KJ, Shea LD: Nerve growth factor expression by PLG-mediated lipofection. Biomaterials. 2006, 27: 2477-2486. 10.1016/j.biomaterials.2005.11.016.

  56. 56.

    Salvay DM, Shea LD: Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol BioSyst. 2006, 2: 36-48. 10.1039/b514174p.

  57. 57.

    Xiaoyun X, Hanry Y, Shujun G, Hai-Quan M, Kam WL, Shu W: Polyphosphoester microspheres for sustained release of biologically active nerve growth factor. Biomaterials. 2002, 23: 3765-3772. 10.1016/S0142-9612(02)00116-3.

  58. 58.

    Sun W, Sun C, Lin H, Zhao H, Wang J, Ma H, Chen B, Xiao Z, Dai J: The effect of collagen-binding NGF-b on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model. Biomaterials. 2009, 30: 4649-4656. 10.1016/j.biomaterials.2009.05.037.

  59. 59.

    Haoqing C, Ting L, Sing YC: The application of nanofibrous scaffolds in neural tissue engineering. Advanced Drug Delivery Reviews. 2009, 61: 1055-1064. 10.1016/j.addr.2009.07.009.

  60. 60.

    Sundback CA, Shyu JY, Wang Y, Faquin WC, Langer RS, Vacanti JP, Hadlock TA: Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials. 2005, 26: 5454-5464. 10.1016/j.biomaterials.2005.02.004.

  61. 61.

    Chen PR, Chen MH, Lin FH, Su WY: Release characteristics and bioactivity of gelatin-tricalcium phosphate membranes covalently immobilized with nerve growth factors. Biomaterials. 2005, 26: 6579-6587. 10.1016/j.biomaterials.2005.03.037.

  62. 62.

    Uwe F, Andreas H, Petra BW, Katja S, Sigrid CS, Milauscha G, Andrea Z, Woranan P, Stefan Z, Dorit M, Alexander S, Carsten W: A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials. 2009, 30: 5049-5060. 10.1016/j.biomaterials.2009.06.002.

  63. 63.

    Amado S, Simoes MJ, Armada da Silva PAS, Luis AL, Shirosaki Y, Lopes MA, Santos JD, Fregnan F, Gambarotta G, Ramimondo S, Fornaro M, Veloso AP, Varejao ASP, Mauricio AC, Geuna S: Use of hybrid chitosan membranes and N1E-115 cells for promoting nerve regeneration in an axonotmesis rat model. Biomaterials. 2008, 29: 4409-4419. 10.1016/j.biomaterials.2008.07.043.

  64. 64.

    Haile Y, Berski S, Drager G, Nobre A, Stummeyer K, Gerardy-Schahn R, Grothe C: The effect of modified polysialic acid based hydrogels on the adhesion and viability of primary neurons and glial cells. Biomaterials. 2008, 29: 1880-1891. 10.1016/j.biomaterials.2007.12.030.

  65. 65.

    Novikova LN, Pettersson J, Brohlin M, Wiberg M, Novikov LN: Biodegradable poly-b-hydroxybutyrate scaffold seeded with Schwann cells to promote spinal cord repair. Biomaterials. 2008, 29: 1198-1206. 10.1016/j.biomaterials.2007.11.033.

  66. 66.

    Lee J, Cuddihy MJ, Kotov NA: Three-dimensional cell culture Matrices: State of the Art. Tissue engineering Part B. 2008, 14: 61-86. 10.1089/teb.2007.0150.

  67. 67.

    Chew SY, Mi R, Hoke A, Leong KW: The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturation. Biomaterials. 2008, 29: 653-661. 10.1016/j.biomaterials.2007.10.025.

  68. 68.

    Oh SH, Kim JH, Song KS, Jeon BH, Yoon JH, Seo TB, Namgung U, Lee IW, Lee JH: Peripheral nerve regeneration within an asymmetrically porous PLGA/Pluronic F127 nerve guide conduit. Biomaterials. 2008, 29: 1601-1609. 10.1016/j.biomaterials.2007.11.036.

  69. 69.

    Zhang Z, Rouabhia M, Wang Z, Roberge C, Shi G, Roche P, Li J, Dao LH: Electrically conductive biodegradable polymer composite for nerve regeneration: electricity-stimulated neurite outgrowth and axon regeneration. Artif Organs. 2007, 31: 13-22. 10.1111/j.1525-1594.2007.00335.x.

  70. 70.

    Crompton KE, Goud JD, Bellamkonda RV, Gengenbach TR, Finkelstein DI, Hornet MK, Forsythe JS: Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering. Biomaterials. 2007, 28: 441-449. 10.1016/j.biomaterials.2006.08.044.

  71. 71.

    Schnell E, Klinkhammer K, Balzer S, Brook G, Klee D, Dalton P, Mey J: Guidance of glial cell migration and axonal growth on electrospun nanofibers of poly-e-caprolactone and a collagen/poly-e-caprolactone blend. Biomaterials. 2007, 28: 3012-3025. 10.1016/j.biomaterials.2007.03.009.

  72. 72.

    Duan X, McLaughlin C, Griffith M, Sheardown H: Biofunctionalization of collagen for improved biological response: Scaffolds for corneal tissue engineering. Biomaterials. 2007, 28: 78-88. 10.1016/j.biomaterials.2006.08.034.

  73. 73.

    Bettinger CJ, Orrick B, Misra A, Langer R, Borenstein JT: Microfabrication of poly (glycerol-sebacate) for contact guidance applications. Biomaterials. 2006, 27: 2558-2565. 10.1016/j.biomaterials.2005.11.029.

  74. 74.

    Burdick JA, Ward M, Liang E, Young MJ, Langer R: Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials. 2006, 27: 452-459. 10.1016/j.biomaterials.2005.06.034.

  75. 75.

    Bini TB, Gao S, Xu X, Wang S, Ramakrishna S, Leong KW: Peripheral nerve regeneration by microbraided poly(L-lactide-co-glycolide) biodegradable polymer fibers. J Biomed Mater Res. 2004, 68A: 286-295. 10.1002/jbm.a.20050.

  76. 76.

    Sundbacka C, Hadlock T, Cheney M, Vacanti J: Manufacture of porous polymer nerve conduits by a novel low-pressure injection molding process. Biomaterials. 2003, 24: 819-830. 10.1016/S0142-9612(02)00409-X.

  77. 77.

    Flynn L, Dalton PD, Shoichet MS: Fiber templating of poly (2-hydroxyethyl methacrylate) for neural tissue engineering. Biomaterials. 2003, 24: 4265-4272. 10.1016/S0142-9612(03)00334-X.

  78. 78.

    Dalton PD, Flynn L, Shoichet MS: Manufacture of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel tubes for use as nerve guidance channels. Biomaterials. 2002, 23: 3843-3851. 10.1016/S0142-9612(02)00120-5.

  79. 79.

    Bini TB, Gao S, Wang S, Ramakrishna S: Development of fibrous biodegradable polymer conduits for guided nerve regeneration. J Mater Sci Mater Med. 2005, 16: 367-375. 10.1007/s10856-005-0637-6.

  80. 80.

    Evans GRD, Brandt K, Widmer MS, Lu L, Meszlenyi RK, Gupta PK, Mikos AG, Hodges J, Williams J, Gurlek A, Nabawi A, Lohman R, Patrick CW: In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials. 1999, 20: 1109-1115. 10.1016/S0142-9612(99)00010-1.

  81. 81.

    Evans GRD, Brandt K, Katz S, Chauvin P, Otto L, Bogle M, Wang B, Meszlenyi RK, Lu L, Mikos AG, Patrick CW: Bioactive poly(l-lactic acid) conduits seeded with Schwann cells for peripheral nerve regeneration. Biomaterials. 2002, 23: 841-848. 10.1016/S0142-9612(01)00190-9.

  82. 82.

    Widmer MS, Gupta PK, Lu L, Meszlenyi R, Evans GRD, Brandt K, Savel T, Gurlek A, Patrick CW, Mikos AG: Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials. 1998, 19: 1945-1955. 10.1016/S0142-9612(98)00099-4.

  83. 83.

    Cheng M, Deng J, Yang F, Gong Y, Zhao N, Zhang X: Study on physical properties and nerve cell affinity of composite films from chitosan and gelatin solutions. Biomaterials. 2003, 24: 2871-2880. 10.1016/S0142-9612(03)00117-0.

  84. 84.

    Cheng M, Cao W, Gao Y, Gong Y, Zhao N, Zhang X: Studies on nerve cell affinity of biodegradable modified chitosan films. J Biomater Sci Polym Ed. 2003, 14: 1155-1167. 10.1163/156856203769231628.

  85. 85.

    Rowlands AS, Lim SA, Martin D, Cooper-White JJ: Polyurethane/poly(lactic-co-glycolic) acid composite scaffolds fabricated by thermally induced phase separation. Biomaterials. 2007, 28: 2109-2121. 10.1016/j.biomaterials.2006.12.032.

  86. 86.

    Freier T, Montenegro R, Shan Koh H, Shoichet MS: Chitin-based tubes for tissue engineering in the nervous system. Biomaterials. 2005, 26: 4624-4632. 10.1016/j.biomaterials.2004.11.040.

  87. 87.

    Wang X, Hu W, Cao Y, Yao J, Wu J, Gu X: Dog sciatic nerve regeneration across a 30-mm defect bridged by a chitosan/PGA artificial nerve graft. Brain. 2005, 128: 1897-1910. 10.1093/brain/awh517.

  88. 88.

    Haishan J, Jian Y, Yumin Y, Xue C, Weiwei L, Yi L, Xiaosong G, Xiaodong W: Chitosan/polyglycolic acid nerve grafts for axon regeneration from prolonged axotomized neurons to chronically denervated segments. Biomaterials. 2009, 30: 5004-5018. 10.1016/j.biomaterials.2009.05.059.

  89. 89.

    Bergethon PR, Trinkaus-Randall V, Franzblau C: Modified hydroxyethylmethacrylate hydrogels as a modelling tool for the study of cell-substratum interactions. J Cell Sci. 1989, 92: 111-121.

  90. 90.

    Gupta D, Tator CH, Shoichet MS: Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials. 2006, 27: 2370-2379. 10.1016/j.biomaterials.2005.11.015.

  91. 91.

    Dhoot NO, Tobias CA, Fischer I, Wheatley MA: Peptide-modified alginate surfaces as a growth permissive substrate for neurite outgrowth. J Biomed Mater Res. 2004, 71A: 191-200. 10.1002/jbm.a.30103.

  92. 92.

    Yu TT, Shoichet MS: Guided cell adhesion and outgrowth in peptide-modified channels for neural tissue engineering. Biomaterials. 2005, 26: 1507-1514. 10.1016/j.biomaterials.2004.05.012.

  93. 93.

    He W, Bellamkonda RV: Nanoscale neuro-integrative coatings for neural implants. Biomaterials. 2005, 26: 2983-2990. 10.1016/j.biomaterials.2004.08.021.

  94. 94.

    Kapur TA, Shoichet MS: Chemically-bound nerve growth factor for neural tissue engineering applications. J Biomater Sci Polym Ed. 2003, 14: 383-394. 10.1163/156856203321478883.

  95. 95.

    Dillon GP, Yu X, Sridharan A, Ranieri JP, Bellamkonda RV: The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. J Biomater Sci Polym Ed. 1998, 9: 1049-1069. 10.1163/156856298X00325.

  96. 96.

    Yu LMY, Leipzig ND, Shoichet MS: Promoting neuron adhesion and growth-Review. Materials today. 2008, 11: 36-43. 10.1016/S1369-7021(08)70088-9.

  97. 97.

    Ma PX, Zhang R: Synthetic nano-scale fibrous extracellular matrix. J Biomed Mater Res. 1999, 46: 60-72. 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H.

  98. 98.

    Li Y, Yang S-T: Effects of three dimensional scaffolds on cell organization and tissue development. Biotechnol Bioprocess Eng. 2001, 6: 311-325. 10.1007/BF02932999.

  99. 99.

    Blacher S, Maquet V, Schils F, Martin D, Schoenen J, Moonen G, Jerome R, Pirard J-P: Image analysis of the axonal ingrowth into poly(d,l-lactide) porous scaffolds in relation to the 3-D porous structure. Biomaterials. 2003, 24: 1033-1040. 10.1016/S0142-9612(02)00423-4.

  100. 100.

    Bhang SH, Lim JS, Choi CY, Kwon YK, Kim B-S: The behaviour of neural stem cells on biodegradable synthetic polymers. J Biomater Sci Polymer Edn. 2007, 18: 223-239. 10.1163/156856207779116711.

  101. 101.

    Yim EKF, Reano RM, Pang SW, Yee AF, Chen CS, Leong KW: Nanopattern-induced changes in morphology and motility of smooth muscle cells. Biomaterials. 2005, 26: 5405-5413. 10.1016/j.biomaterials.2005.01.058.

  102. 102.

    Boland ED, Espy PG, Bowlin GL: Enycyclopedia of Biomaterials and Biomedial Engineering. Tissue Engineering Scaffolds. Edited by: Wnek GE, Bowlin GL. 2008, New York: Informa Healthcare USA, Inc, 1: 2828-2837. 2

  103. 103.

    Drury JL, Mooney DJ: Hydrogels for tissue engineering: Scaffolddesign variables and applications. Biomaterials. 2003, 24: 4337-4351. 10.1016/S0142-9612(03)00340-5.

  104. 104.

    Woerly S, Marchand R, Lavallee C: Intracerebral implantation of synthetic polymer/biopolymer matrix: a new perspective for brain repair. Biomaterials. 1990, 11: 97-107. 10.1016/0142-9612(90)90123-8.

  105. 105.

    Balgude AP, Yu X, Szymanski A, Bellamkonda RV: Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures. Biomaterials. 2001, 22: 1077-1084. 10.1016/S0142-9612(00)00350-1.

  106. 106.

    Woerly S, Doan VD, Evans-Martin F, Paramore CG, Peduzzi JD: Spinal cord reconstruction using NeuroGel implants and functional recovery after chronic injury. J Neurosci Res. 2001, 66: 1187-1197. 10.1002/jnr.1255.

  107. 107.

    Woerly S, Pinet E, Robertis LD, Bousmina M, Laroche G, Roitback T, Vargova L, Sykova E: Heterogeneous PHPMA hydrogels for tissue repair and axonal regeneration in the injured spinal cord. J Biomater Sci Polym Ed. 1998, 9: 681-711. 10.1163/156856298X00091.

  108. 108.

    Woerly S, Plant GW, Harvey AR: Neural tissue engineering: from polymer to biohybrid organs. Biomaterials. 1996, 17: 301-310. 10.1016/0142-9612(96)85568-2.

  109. 109.

    Mahoney MJ, Anseth KS: Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels. Biomaterials. 2006, 27: 2265-2274. 10.1016/j.biomaterials.2005.11.007.

  110. 110.

    Yuan Y, Zhang P, Yang Y, Wang X, Gu X: The interaction of Schwann cells with chitosan membranes and fibers in vitro. Biomaterials. 2004, 25: 4273-4278. 10.1016/j.biomaterials.2003.11.029.

  111. 111.

    Woerly S: Restorative surgery of the central nervous system by means of tissue engineering using NeuroGel implants. Neurosurg Rev. 2000, 23: 59-77.

  112. 112.

    Tian WM, Hou SP, Ma J, Zhang CL, Xu QY, Lee IS, Li HD, Spector M, Cui FZ: Hyaluronic acid-poly-D-lysine-based three-dimensional hydrogel for traumatic brain injury. Tissue Eng. 2005, 11: 513-525. 10.1089/ten.2005.11.513.

  113. 113.

    Musoke-Zawedde P, Shoichet MS: Anisotropic three-dimensional peptide channels guide neurite outgrowth within a biodegradable hydrogel matrix. Biomed Mater. 2006, 1: 162-169. 10.1088/1748-6041/1/3/011.

  114. 114.

    Katayama Y, Montenegro R, Freier T, Midha R, Belkas JS, Shoichet MS: Coil-reinforced hydrogel tubes promote nerve regeneration equivalent to that of nerve autografts. Biomaterials. 2006, 27: 505-518. 10.1016/j.biomaterials.2005.07.016.

  115. 115.

    Bhattarai N, Edmondson D, Veiseh O, Matsen FA, Zhang M: Electrospun chitosan-based nanofibers and their cellular compatibility. Biomaterials. 2005, 26: 6176-6184. 10.1016/j.biomaterials.2005.03.027.

  116. 116.

    Cao H, Liu T, Chew SY: The application of nanofibrous scaffolds in neural tissue engineering. Advanced Drug Delivery Reviews. 61 (12): 1055-64. 10.1016/j.addr.2009.07.009.

  117. 117.

    Liao S, Li B, Ma Z, Wei H, Chan C, Ramakrishna S: Biomimetic electrospun nanofibers for tissue regeneration. Biomed Mater. 2006, 1: R45-R53. 10.1088/1748-6041/1/3/R01.

  118. 118.

    Panseri S, Cunha C, Lowery J, Carro UD, Taraballi F, Amadio S, Vescovi A, Gelain F: Electrospun micro- and nanofiber tubes for functional nervous regeneration in sciatic nerve transections. BMC Biotechnology. 2008, 8: 39-50. 10.1186/1472-6750-8-39.

  119. 119.

    Bini TB, Gao S, Wang S, Ramakrishna S: Poly(l-lactide-co-glycolide) biodegradable microfibers and electrospun nanofibers for nerve tissue engineering: an in vitro study. J Mater Sci. 2006, 41: 6453-6459. 10.1007/s10853-006-0714-3.

  120. 120.

    Ji Y, Ghosh K, Shu XZ, Li B, Sokolov JC, Prestwich GD, Clark RA, Rafailovich MH: Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds. Biomaterials. 2006, 27: 3782-3792. 10.1016/j.biomaterials.2006.02.037.

  121. 121.

    Kim Y, Haftel VK, Kumar S, Bellamkonda R: The role of aligned polymer fiber-based constructs in bridging of long peripheral nerve gaps. Biomaterials. 2008, 29: 3117-3127. 10.1016/j.biomaterials.2008.03.042.

  122. 122.

    Moore MJ, Friedman JA, Lewellyn EB, Mantila SM, Krych AJ, Ameenuddin S, Knight AM, Lu L, Currier BL, Spinner RJ, Marsh RW, Windebank AJ, Yaszemski MJ: Multiple-channel scaffolds to promote spinal cord axon regeneration. Biomaterials. 2006, 27: 419-429. 10.1016/j.biomaterials.2005.07.045.

  123. 123.

    Bender MD, Bennett JM, Waddell RL, Doctor JS, Marra KG: Multi-channeled biodegradable polymer/CultiSpher composite nerve guides. Biomaterials. 2004, 25: 1269-1278. 10.1016/j.biomaterials.2003.08.046.

  124. 124.

    Schmalenberg KE, Uhrich KE: Micropatterned polymer substrates control alignment of proliferating schwann cells to direct neuronal regeneration. Biomaterials. 2005, 26: 1423-1430. 10.1016/j.biomaterials.2004.04.046.

  125. 125.

    Recknor JB, Sakaguchi DS, Mallapragada SK: Directed growth on selective differentiation of neural progenitor cells on micropatterned polymer substrates. Biomaterials. 2006, 27: 4098-4108. 10.1016/j.biomaterials.2006.03.029.

  126. 126.

    Miller C, Shanks H, Witt A, Rutkowski G, Mallapragada S: Oriented Schwann cell growth on micropatterned biodegradable polymer substrates. Biomaterials. 2001, 22: 1263-1269. 10.1016/S0142-9612(00)00278-7.

  127. 127.

    Rivers TJ, Hudson TW, Schmidt CE: Synthesis of a novel, biodegradable electrically conducting polymer for biomedical applications. Adv Funct Mater. 2002, 12: 33-37. 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E.

  128. 128.

    Kotwal A, Schmidt CE: Electrical stimulation alters protein adsorption and nerve cell interactions with electrically conducting biomaterials. Biomaterials. 2001, 22: 1055-1064. 10.1016/S0142-9612(00)00344-6.

  129. 129.

    Lee Jae, Bashur Chris, Goldstein Aaron, Schmidt Christine: Polypyrrole-coated electrospun PLGA nanofibers for neural tissue applications. Biomaterials. 2009, 30: 4325-4335. 10.1016/j.biomaterials.2009.04.042.

  130. 130.

    Kilmartin PA, Gizdavic-Nikolaidis M, Zujovic Z, Travas-Sejdic J, Bowmaker GA, Cooney RP: Free radical scavenging and antioxidant properties of conducting polymer examined using EPR and NMR spectroscopies. Synth Met. 2005, 153: 153-156. 10.1016/j.synthmet.2005.07.170.

  131. 131.

    Gizdavic-Nikolaidis M, Travas-Sejdic J, Bowmaker GA, Cooney RP, Thompson C, Kilmartin PA: The antioxidant activity of conducting polymers in biomedical applications. Curr Appl Phys. 2004, 4: 347-350. 10.1016/j.cap.2003.11.045.

  132. 132.

    Stauffer WR, Cui XT: Polypyrrole doped with 2 peptide sequences from laminin. Biomaterials. 2006, 27: 2405-2413. 10.1016/j.biomaterials.2005.10.024.

  133. 133.

    Lee JW, Serna F, Nickels J, Schmidt CE: Carboxylic acid-functionalized conductive polypyrrole as a bioactive platform for cell adhesion. Biomacromolecules. 2006, 7: 1692-1695. 10.1021/bm060220q.

  134. 134.

    Valle LJ, Aradilla D, Oliver R, Sepulcre F, Gamez A, Armelin E, Aleman C, Estrany F: Cellular adhesion and proliferation on poly(3,4-ethylenedioxythiophene): Benefits in the electroactivity of the conducting polymer. European Polymer Journal. 2007, 43: 2342-2349. 10.1016/j.eurpolymj.2007.03.050.

  135. 135.

    Patel N, Poo M-M: Orientation of neurite growth by extracellular electric fields. J Neurosci. 1982, 2: 483-496.

Download references

Author information

Correspondence to Swaminathan Sethuraman.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

All authors have equal contribution in the preparation of the manuscript.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Authors’ original file for figure 3

Rights and permissions

Reprints and Permissions

About this article

Keywords

  • Schwann Cell
  • Neurite Outgrowth
  • Polypyrrole
  • Nerve Regeneration
  • Nanofibrous Scaffold